On August 17, 2018 RhoVac AB ("RhoVac") reported that it will attend Nordic Life Science Days, Stockholm in September and at BIO-Europe, Copenhagen in November (Press release, RhoVac, AUG 17, 2018, View Source [SID1234529024]). The company will also attend three investment events in the fall.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

RhoVac will attend Nordic Life Science Days, Stockholm Waterfront, Stockholm between 10 and 12 September, and at BIO – Europe in Copenhagen, Denmark between 5 and 7 November. At BIO-Europe, over 2 200 different companies, academic institutions and other related organizations from more than 60 other countries attend.

RhoVac’s CEO Anders Ljungqvist will present the company at the Sedemeradagen in Göteborg (11th October, Elite Hotel) and be interviewed in Stockholm (7th November, Waterfront Congress Center). Registration for these events via Sedermera’s website, View Source

The company will also present at Aktiepararnas Aktieträff in Kristianstad on 30th August. Registration can be done via: View Source

For more information, please contact:
Anders Ljungqvist – VD, RhoVac AB
Phone: +45 4083 2365
E-mail: [email protected]